| Application no. and date | 03789346.8 (espacenet) (Federated) (European Patent Register), 20031218 | | Patent/reg. no. and date | DK/EP 1572233, 20110330 | | Publication date | 20050914 | | Priority no. and date | US 435035 P, 20021220, US 496653 P, 20030820 | | EP pub. no. and date |
EP 1572233 20050914 | | Effective date | | | Applicant/owner | GlaxoSmithKline Biologicals s.a., rue de l'Institut 89
1330 Rixensart, BE | | Applicant ref. no. | 154881 | | Inventor | DUBIN, Gary
GlaxoSmithKline, 2301 Renaissance Blv.RN0220
Bldg.510,PO.Box 61540
King of Prussia,PA 19 406-2772, US,
INNIS, Bruce
GlaxoSmithKline, 2301 Renaissance Blv.RN0220
Bldg.510,PO.Box 61540
King of Prussia, PA 19406-2772, US,
WETTENDORFF, M.A.C.
GlaxoSmithKlineBiologicals SA, rue de l'Institut 89
B-1330 Rixensart, BE,
SLAOUI, Moncef, M.
GlaxoSmithKline, 709 Swedeland Road
King of Prussia, Pennsylvania 19406, US | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 39/12 (2006.01) | | Title | Anvendelse af HPV16 og HPV18 som vaccine mod et eller flere onkogene HPV-vira af typerne 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68 | | Int. application no. | EP2003014562 | | Int. publication no. | WO2004056389 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
